Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06884098
PHASE1
A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284
Sponsor: Addpharma Inc.
View on ClinicalTrials.gov
Summary
Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-228B in healthy subjects.
Official title: An Open-label, Randomized, Fasting, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Bioequivalence of AD-228B with AD-2284 in Healthy Adult Volunteers
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-03-10
Completion Date
2025-04
Last Updated
2025-03-20
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
AD-228B
AD-228B, 1Tab., Per Oral
DRUG
AD-2284
AD-2284, 1Tab., Per Oral
Locations (1)
H Plus Yangji Hospital
Seoul, South Korea